PubMed · 1995 · 35 citations · 0 references
Life SciencesCell BiologyMolecular BiologyGene ExpressionGene Expression AnalysisOncogenesBcl-2 Family ProteinsCartilage BiologyCartilage DegenerationJoint DegenerationOsteoarthritisArticular Cartilage DefectsArticular Cartilage LossBcl-2 Protein ExpressionBcl-2 Protein RegulationDifferential Transcript ExpressionImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical Staining
OBJECTIVE: To investigate the expression of bcl-2 in healthy and osteoarthritic articular cartilage at the transcriptional level and at the protein level. METHODS: bcl-2 mRNA was detected by reverse transcriptase/polymerase chain reaction. The expression of bcl-2 protein was studied using flow cytometry analysis with a monoclonal antibody against intracellular bcl-2 and by immunohistochemistry. RESULTS: mRNA for bcl-2 was detectable in chondrocytes of both healthy and osteoarthritic cartilage. bcl-2 protein was present in the chondrocytes of the middle layer of cartilage by immunohistochemical staining. In osteoarthritis (OA), chondrocytes adjacent to cartilage defects expressed a particularly high signal intensity. Flow cytometry analysis demonstrated the presence of bcl-2 protein in virtually all chondrocytes. CONCLUSION: Our results show that bcl-2 is expressed in healthy adult and osteoarthritic human cartilage. The increased staining of chondrocytes adjacent to osteoarthritic defects indicates a differential regulation of programmed cell death during the degenerative process in OA.